Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Prif Awdur: | Forbes, E |
---|---|
Awduron Eraill: | Hill, A |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Pynciau: |
Eitemau Tebyg
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
gan: Kapulu, MC
Cyhoeddwyd: (2014) -
Developing novel blood-stage malaria vaccines
gan: Douglas, AD
Cyhoeddwyd: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
gan: Bauza, K
Cyhoeddwyd: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
gan: de Cassan, S
Cyhoeddwyd: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
gan: Elias, SC
Cyhoeddwyd: (2014)